Debt-to-equity of Nuvation Bio Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Nuvation Bio Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • Nuvation Bio Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 44%, a 419% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Nuvation Bio Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 44% +36% +419% 30 Sep 2025
Q2 2025 28% +22% +394% 30 Jun 2025
Q1 2025 17% +14% +483% 31 Mar 2025
Q4 2024 13% +10% +354% 31 Dec 2024
Q3 2024 9% +6% +212% 30 Sep 2024
Q2 2024 6% +3% +115% 30 Jun 2024
Q1 2024 3% 0% -0.34% 31 Mar 2024
Q4 2023 3% -1% -17% 31 Dec 2023
Q3 2023 3% -1% -25% 30 Sep 2023
Q2 2023 3% -1% -32% 30 Jun 2023
Q1 2023 3% -1% -21% 31 Mar 2023
Q4 2022 3% 0% -6.2% 31 Dec 2022
Q3 2022 4% 0% +9.6% 30 Sep 2022
Q2 2022 4% +1% +25% 30 Jun 2022
Q1 2022 4% 31 Mar 2022
Q4 2021 4% 31 Dec 2021
Q3 2021 3% 30 Sep 2021
Q2 2021 3% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.